Literature DB >> 27116649

Cost of severe asthma in Brazil-systematic review.

Roberto Stirbulov1, Nilceia Lopes da Silva2, Sarah Cristina Oliveira Machado Maia2, Eduardo Carvalho-Netto2, Luciene Angelini2.   

Abstract

INTRODUCTION: Severe asthma is characterized by frequent exacerbations, symptoms limiting daily activities and nocturnal symptoms. It requires the continuous use of medications, at high doses, and, sometimes, continuous use of oral corticosteroids, representing a significant burden to health system and society. This systematic review sought to address economic data related to severe asthma in Brazil.
METHOD: In June 2014, electronic searches were conducted to identify relevant publications. Quality criteria were developed and applied to each selected study. In order to compare results across the selected studies, costs were refined to an annual basis, grouped according to the study perspective, inflated and converted to 2014 USD.
RESULTS: Cost analyses from the Brazilian public health system perspective were derived from two studies and showed an average annual hospital cost per patient of 135 USD and 733 USD, respectively. From the family perspective, average annual direct costs per patient varied from 764 USD to 929 USD.
CONCLUSION: Hospitalizations and medications seem to be the most important resources funded by the Brazilian public health system and by patients and their families. Although further studies are necessary, as information on cost of this disease is scarce in Brazil, these findings suggest that there is a potential room for improving severe asthma care among Brazilian patients.

Entities:  

Keywords:  Cost of illness; asthma; burden of illness; health care costs; review

Mesh:

Substances:

Year:  2016        PMID: 27116649     DOI: 10.3109/02770903.2016.1171338

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

1.  Severe asthma phenotyping: does the definition of different phenotypes matter?

Authors:  Marcia Margaret Menezes Pizzichini; José Eduardo Delfini Cançado
Journal:  J Bras Pneumol       Date:  2022-07-08       Impact factor: 2.800

2.  The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system.

Authors:  Thiago de Araujo Cardoso; Cristian Roncada; Emerson Rodrigues da Silva; Leonardo Araujo Pinto; Marcus Herbert Jones; Renato Tetelbon Stein; Paulo Márcio Pitrez
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

3.  High health gain patients with asthma: a cross-sectional study analysing national Scottish data sets.

Authors:  Mome Mukherjee; Bright I Nwaru; Ireneous Soyiri; Ian Grant; Aziz Sheikh
Journal:  NPJ Prim Care Respir Med       Date:  2018-07-19       Impact factor: 2.871

Review 4.  2021 Brazilian Thoracic Association recommendations for the management of severe asthma.

Authors:  Regina Maria de Carvalho-Pinto; José Eduardo Delfini Cançado; Marcia Margaret Menezes Pizzichini; Jussara Fiterman; Adalberto Sperb Rubin; Alcindo Cerci Neto; Álvaro Augusto Cruz; Ana Luisa Godoy Fernandes; Ana Maria Silva Araujo; Daniela Cavalet Blanco; Gediel Cordeiro Junior; Lilian Serrasqueiro Ballini Caetano; Marcelo Fouad Rabahi; Marcelo Bezerra de Menezes; Maria Alenita de Oliveira; Marina Andrade Lima; Paulo Márcio Pitrez
Journal:  J Bras Pneumol       Date:  2021-12-15       Impact factor: 2.624

5.  Estimated cost of asthma in outpatient treatment: a real-world study.

Authors:  Eduardo Costa; Rosangela Caetano; Guilherme Loureiro Werneck; Maurício Bregman; Denizar Vianna Araújo; Rogério Rufino
Journal:  Rev Saude Publica       Date:  2018-04-09       Impact factor: 2.106

6.  Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma.

Authors:  Vitor Ponci; Rafael C Silva; Fernanda Paula R Santana; Simone S Grecco; Célia Regina M Fortunato; Maria A Oliveira; Wothan Tavares-de-Lima; Clarice R Olivo; Iolanda de Fátima L Calvo Tibério; Kaio S Gomes; Carla M Prado; João Henrique G Lago
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.